{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "7543732", "DateCompleted": {"Year": "1995", "Month": "09", "Day": "12"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0002-9440", "JournalIssue": {"Volume": "147", "Issue": "2", "PubDate": {"Year": "1995", "Month": "Aug"}}, "Title": "The American journal of pathology", "ISOAbbreviation": "Am J Pathol"}, "ArticleTitle": "Flavonoids inhibit cytokine-induced endothelial cell adhesion protein gene expression.", "Pagination": {"StartPage": "278", "EndPage": "292", "MedlinePgn": "278-92"}, "Abstract": {"AbstractText": ["Treatment of human endothelial cells with cytokines such as interleukin-1, tumor necrosis factor-alpha (TNF-alpha) or interferon-gamma induces the expression of specific leukocyte adhesion molecules on the endothelial cell surface. Interfering with either leukocyte adhesion or adhesion protein upregulation is an important therapeutic target as evidenced by the potent anti-inflammatory actions of neutralizing antibodies to these ligands in various animal models and in patients. In the present study we report that cotreatment of human endothelial cells with certain hydroxyflavones and flavanols blocks cytokine-induced ICAM-1, VCAM-1, and E-selectin expression on human endothelial cells. One of the most potent flavones, apigenin, exhibited a dose- and time-dependent, reversible effect on adhesion protein expression as well as inhibiting adhesion protein upregulation at the transcriptional level. Apigenin also inhibited IL-1 alpha-induced prostaglandin synthesis and TNF-alpha-induced IL-6 and IL-8 production, suggesting that the hydroxyflavones may act as general inhibitors of cytokine-induced gene expression. Although apigenin did not inhibit TNF-alpha-induced nuclear translocation of NF-kappa B(p50(NFKB1)/p65(RelA)) we found this flavonoid did inhibit TNF-alpha induced beta-galactosidase activity in SW480 cells stably transfected with a beta-galactosidase reporter construct driven by four NF-kappa B elements, suggesting an action on NF-kappa B transcriptional activation. Adhesion of leukocytes to cytokine-treated endothelial cells was blocked in endothelial cells cotreated with apigenin. Finally, apigenin demonstrated potent anti-inflammatory activity in carrageenan induced rat paw edema and delayed type hypersensitivity in the mouse. We conclude that flavonoids offer important therapeutic potential for the treatment of a variety of inflammatory diseases involving an increase in leukocyte adhesion and trafficking."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute for Bone and Joint Disease and Cancer, Bayer Corporation, West Haven, Connecticut 06516, USA."}], "LastName": "Gerritsen", "ForeName": "M E", "Initials": "ME"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Carley", "ForeName": "W W", "Initials": "WW"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Ranges", "ForeName": "G E", "Initials": "GE"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Shen", "ForeName": "C P", "Initials": "CP"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Phan", "ForeName": "S A", "Initials": "SA"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Ligon", "ForeName": "G F", "Initials": "GF"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Perry", "ForeName": "C A", "Initials": "CA"}], "PublicationTypeList": ["Comparative Study", "Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Am J Pathol", "NlmUniqueID": "0370502", "ISSNLinking": "0002-9440"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cell Adhesion Molecules"}, {"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "0", "NameOfSubstance": "E-Selectin"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Molecular Probes"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "Oils, Volatile"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA, Messenger"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Necrosis Factor-alpha"}, {"RegistryNumber": "0", "NameOfSubstance": "Vascular Cell Adhesion Molecule-1"}, {"RegistryNumber": "126547-89-5", "NameOfSubstance": "Intercellular Adhesion Molecule-1"}, {"RegistryNumber": "9007-49-2", "NameOfSubstance": "DNA"}], "CommentsCorrectionsList": [{"RefSource": "Am J Pathol. 1995 Aug;147(2):235-7.", "PMID": "7639322"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Base Sequence"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Cell Adhesion Molecules"}, {"QualifierName": [], "DescriptorName": "Chamomile"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Cytokines"}, {"QualifierName": ["genetics"], "DescriptorName": "Cytomegalovirus"}, {"QualifierName": ["metabolism"], "DescriptorName": "DNA"}, {"QualifierName": [], "DescriptorName": "E-Selectin"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Flavonoids"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemically induced"], "DescriptorName": "Inflammation"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Intercellular Adhesion Molecule-1"}, {"QualifierName": ["genetics"], "DescriptorName": "Molecular Probes"}, {"QualifierName": [], "DescriptorName": "Molecular Sequence Data"}, {"QualifierName": ["genetics", "physiology"], "DescriptorName": "NF-kappa B"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Oils, Volatile"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug effects"], "DescriptorName": "Promoter Regions, Genetic"}, {"QualifierName": ["metabolism"], "DescriptorName": "RNA, Messenger"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Tumor Necrosis Factor-alpha"}, {"QualifierName": [], "DescriptorName": "Vascular Cell Adhesion Molecule-1"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "J Clin Invest. 1973 Nov;52(11):2745-56", "ArticleIdList": ["4355998"]}, {"Citation": "Prostaglandins. 1980 Oct;20(4):627-39", "ArticleIdList": ["6781013"]}, {"Citation": "J Invest Dermatol. 1982 Mar;78(3):206-9", "ArticleIdList": ["6276474"]}, {"Citation": "Lab Invest. 1982 Jul;47(1):60-6", "ArticleIdList": ["6177923"]}, {"Citation": "Agents Actions. 1982 Jul;12(3):298-302", "ArticleIdList": ["6982607"]}, {"Citation": "Int J Microcirc Clin Exp. 1983;2(1):39-46", "ArticleIdList": ["6088413"]}, {"Citation": "J Cell Biol. 1984 Dec;99(6):2034-40", "ArticleIdList": ["6501412"]}, {"Citation": "J Pharm Pharmacol. 1984 Dec;36(12):820-3", "ArticleIdList": ["6151974"]}, {"Citation": "J Clin Invest. 1985 Nov;76(5):2003-11", "ArticleIdList": ["3877078"]}, {"Citation": "J Immunol Methods. 1986 May 22;89(2):271-7", "ArticleIdList": ["3486233"]}, {"Citation": "Biochem Pharmacol. 1988 Mar 1;37(5):837-41", "ArticleIdList": ["2830882"]}, {"Citation": "J Pharm Pharmacol. 1988 Apr;40(4):293-5", "ArticleIdList": ["2900316"]}, {"Citation": "Science. 1989 Mar 3;243(4895):1160-5", "ArticleIdList": ["2466335"]}, {"Citation": "J Immunol. 1989 Apr 1;142(7):2257-63", "ArticleIdList": ["2564407"]}, {"Citation": "Proc Natl Acad Sci U S A. 1989 Apr;86(7):2336-40", "ArticleIdList": ["2494664"]}, {"Citation": "Pharmacol Res Commun. 1988 Dec;20 Suppl 5:91-4", "ArticleIdList": ["3150058"]}, {"Citation": "Biochem Pharmacol. 1989 May 15;38(10):1617-24", "ArticleIdList": ["2730676"]}, {"Citation": "Differentiation. 1989 Oct;42(1):44-53", "ArticleIdList": ["2482821"]}, {"Citation": "Nature. 1990 Aug 2;346(6283):425-34", "ArticleIdList": ["1974032"]}, {"Citation": "Free Radic Biol Med. 1990;9(1):19-21", "ArticleIdList": ["2170243"]}, {"Citation": "J Biol Chem. 1991 Feb 5;266(4):2466-73", "ArticleIdList": ["1703529"]}, {"Citation": "Biochim Biophys Acta. 1991 Apr 16;1072(1):63-80", "ArticleIdList": ["2018779"]}, {"Citation": "Nucleic Acids Res. 1991 May 25;19(10):2645-53", "ArticleIdList": ["1710341"]}, {"Citation": "J Biol Chem. 1991 Jul 25;266(21):14024-30", "ArticleIdList": ["1677359"]}, {"Citation": "Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6523-7", "ArticleIdList": ["1713680"]}, {"Citation": "Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7859-63", "ArticleIdList": ["1715583"]}, {"Citation": "J Immunol. 1991 Oct 15;147(8):2777-86", "ArticleIdList": ["1680919"]}, {"Citation": "J Immunol. 1991 Dec 15;147(12):4167-71", "ArticleIdList": ["1684374"]}, {"Citation": "Biochem Pharmacol. 1992 Mar 17;43(6):1167-79", "ArticleIdList": ["1562270"]}, {"Citation": "J Biol Chem. 1992 Sep 25;267(27):19226-32", "ArticleIdList": ["1382069"]}, {"Citation": "Eur J Immunol. 1992 Nov;22(11):3045-8", "ArticleIdList": ["1330580"]}, {"Citation": "FASEB J. 1993 Apr 1;7(6):523-32", "ArticleIdList": ["8472891"]}, {"Citation": "Arthritis Rheum. 1993 May;36(5):593-602", "ArticleIdList": ["8098213"]}, {"Citation": "J Exp Med. 1994 Feb 1;179(2):503-12", "ArticleIdList": ["7507507"]}, {"Citation": "J Biol Chem. 1995 Jan 13;270(2):933-43", "ArticleIdList": ["7822333"]}], "ReferenceList": []}], "History": [{"Year": "1995", "Month": "8", "Day": "1"}, {"Year": "1995", "Month": "8", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1995", "Month": "8", "Day": "1", "Hour": "0", "Minute": "0"}, {"Year": "1996", "Month": "2", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["7543732", "PMC1869822"]}}]}